EGFR and head and neck squamous cell carcinoma: It has been shown that blocking EGFR might also affect the mechanisms of resistance to immunotherapy 7, suggesting that the coordinated interruption of cooperative survival signaling pathways 8-10 in HNSCC 8,11,12 is necessary for optimal therapeutic results.